Notice Number: NOT-OD-17-070
Key Dates
Release Date: June 5, 2017
Issued by
National Institutes of Health (NIH)
Centers for Disease Control and Prevention (CDC)
U.S. Food and Drug Administration (FDA)
Purpose
The 2017 Omnibus Grant Solicitations of the NIH, CDC, and FDA are now available for the SBIR and STTR (NIH only) programs.
The 2017 SBIR/STTR Omnibus solicitations and accompanying resources can be found below:
Standard Application Due Dates: September 5, 2017 and January 5, 2018.
*** These Omnibus FOAs are being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. These FOAs will be reissued for additional due date(s) on or after January 25, 2018.***
Please see https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-062.html.
HHS expects to re-issue these Omnibus after the January 5, 2018 due date.
Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms CONTINUE TO BE ELIGIBLE to apply to the CDC and NIH SBIR program and compete for up to 15% and 25% respectively of each agency's SBIR set-aside.
An informational webinar will occur on Thursday June 29, 2017 at 2:00 PM to 3:30 PM EDT.
Please register for HHS SBIR/STTR PHS 2017-2 Grant Omnibus Webinar on June 29, 2017 2:00 PM EDT at:Inquiries
Please direct all inquiries to:
NIH SBIR/STTR Program Office
Telephone: 301-435-2688
Fax: 301-480-0146
Email: [email protected]
Website: http://sbir.nih.gov